PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $47,000 | -44.7% | 21,796 | -32.3% | 0.00% | -20.0% |
| Q3 2018 | $85,000 | +174.2% | 32,213 | +146.4% | 0.01% | +400.0% |
| Q2 2018 | $31,000 | +3.3% | 13,072 | +17.6% | 0.00% | -50.0% |
| Q4 2017 | $30,000 | -79.6% | 11,114 | -74.4% | 0.00% | -71.4% |
| Q3 2017 | $147,000 | -33.5% | 43,434 | +26.4% | 0.01% | -65.0% |
| Q2 2015 | $221,000 | – | 34,355 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |